| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/26/2012 | WO2011051354A4 Transdermal pharmaceutical compositions comprising active agents |
| 04/26/2012 | US20120101593 Implantable polymer for bone and vascular lesions |
| 04/26/2012 | US20120101535 Bone repair putty |
| 04/26/2012 | US20120101172 Liquid or pourable proteosome-forming bath and shower concentrates, galenic application products thereof, and their use |
| 04/26/2012 | US20120101148 lipid formulation |
| 04/26/2012 | US20120101141 Gel compositions and methods of use |
| 04/26/2012 | US20120101135 Composition containing sorbitan monocaprylate and antimicrobial substances |
| 04/26/2012 | US20120101104 Topical gel compositions and methods of use |
| 04/26/2012 | US20120101088 Transmembrane Penetration Enhancer |
| 04/26/2012 | US20120101041 Polyionic dendrimer and hydrogel comprising same |
| 04/26/2012 | US20120100575 Antibodies having altered effector function and methods for making the same |
| 04/26/2012 | US20120100234 Non-occluding nasal moisturizer and methods of use |
| 04/26/2012 | US20120100219 Composition for the production of tablets, and method for the production of said composition |
| 04/26/2012 | US20120100217 Polymeric material |
| 04/26/2012 | US20120100200 System And Method For Satellite Drug Delivery |
| 04/26/2012 | US20120100197 Novel esters, and use thereof |
| 04/26/2012 | US20120100190 Controlled release sterile injectable aripiprazole formulation and method |
| 04/26/2012 | US20120100183 Topical base and active agent-containing compositions, and methods for improving and treating skin |
| 04/26/2012 | US20120100149 Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent |
| 04/26/2012 | US20120100096 Conjugates pf small-interfering nucleic acids |
| 04/26/2012 | US20120100084 Polymers based on arcrylic, methacrylic or ethacrylic amidoalkyl sulfonic acid or salts and carboxyalky acrylate, methacrylate or ethacrylate or oligomers of said carboxy compounds |
| 04/26/2012 | US20120100077 Mixture of amphipathic molecules and method for modifying cell membranes by means of fusion |
| 04/26/2012 | DE102010050457A1 Verbesserte pharmazeutische Starterpellets Improved pharmaceutical starter pellets |
| 04/26/2012 | CA2815363A1 Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mtor pathway |
| 04/26/2012 | CA2815145A1 Metal ion nanoclusters |
| 04/26/2012 | CA2814975A1 Topical gel composition |
| 04/26/2012 | CA2814952A1 Brimonidine gel compositions and methods of use |
| 04/26/2012 | CA2814927A1 Compositions for drug administration |
| 04/26/2012 | CA2814840A1 Sustained-release formulation for injection |
| 04/26/2012 | CA2814805A1 Ready to use ketorolac formulations |
| 04/26/2012 | CA2814577A1 Use of storage stable viscous phospholipid depot to treat wounds |
| 04/26/2012 | CA2814103A1 Pharmaceutical topical composition of mupirocin |
| 04/26/2012 | CA2813016A1 Liquid pharmaceutical composition for the delivery of active ingredients |
| 04/26/2012 | CA2812187A1 Topical base and active agent-containing compositions, and methods for improving and treating skin |
| 04/25/2012 | EP2444425A1 1:1, 2:1 or 3:1 complex consisting of a cyclodextrin or cyclodextrin derivative and a halogenated ether, production therof and use therof as soporific |
| 04/25/2012 | EP2444398A2 Novel intermediates of voriconazole and preparation method of voriconazole using the same |
| 04/25/2012 | EP2444069A1 Controlled release compositions |
| 04/25/2012 | EP2444068A1 Brimonidine gel composition |
| 04/25/2012 | EP2444067A1 Anhydrous gel comprising mupirocin |
| 04/25/2012 | EP2444065A1 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 04/25/2012 | EP2444063A1 Liquid pharmaceutical compositions for the delivery of active ingredients |
| 04/25/2012 | EP2444061A1 Apigenin-containing composition |
| 04/25/2012 | EP2443150A2 Anti-vegf antibodies and their uses |
| 04/25/2012 | EP2443137A1 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
| 04/25/2012 | EP2442832A1 Compositions and methods for treatment of multiple sclerosis |
| 04/25/2012 | EP2442831A2 Materials and methods relating to glycosylation |
| 04/25/2012 | EP2442830A2 Hemostatic material and delivery device |
| 04/25/2012 | EP2442813A1 A medicinal anti acne cream comprising chitosan and a process to make it |
| 04/25/2012 | EP2442805A1 Nanodispersion of a drug and process for its preparation |
| 04/25/2012 | EP2442800A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 04/25/2012 | EP2442797A1 Dendrimer based nanodevices for therapeutic and imaging purposes |
| 04/25/2012 | EP2442790A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 04/25/2012 | EP2442789A1 Stable nanoparticulate drug suspension |
| 04/25/2012 | EP2442650A1 Sublingual apomorphine |
| 04/25/2012 | EP2288375B1 Pegylated insulin lispro compounds |
| 04/25/2012 | EP2257624B1 Methods and compositions |
| 04/25/2012 | EP2178519B1 Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer |
| 04/25/2012 | EP2146727B1 High viscosity macromolecular compositions for treating ocular conditions |
| 04/25/2012 | EP2068909B1 Modified fgf-21 polypeptides and their uses |
| 04/25/2012 | EP1919529B1 Method of removing medical adhesive |
| 04/25/2012 | EP1706150B1 Stable growth hormone liquid formulation |
| 04/25/2012 | EP1682581B1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 04/25/2012 | EP1658079B1 Multivitamin syrup for children or young adults |
| 04/25/2012 | EP1441785B1 Improved method for generating an aerosol |
| 04/25/2012 | EP1416970B1 Conjugate |
| 04/25/2012 | EP1381432B9 HSA-free formulations of interferon-beta |
| 04/25/2012 | EP1322597B1 Process and intermediates |
| 04/25/2012 | EP1014953B1 Formulations for hydrophobic pharmaceutical agents |
| 04/25/2012 | CN1929817B 包含特定的p物质拮抗剂的微乳制剂 Contains a specific substance p antagonists microemulsion |
| 04/25/2012 | CN1891298B 用于胃肠外、尤其是血管内药物释放的药物贮库 For parenteral, in particular intravascular drug reservoir of drug release |
| 04/25/2012 | CN1887348B 鸡志贺氏菌灭活铝胶疫苗及其研制方法 Chicken Shigella inactivated vaccine and the development of methods alhydrogel |
| 04/25/2012 | CN1780643B Antiviral phosphonate analogs |
| 04/25/2012 | CN1278733B Viscous compositions containing carbon dioxide |
| 04/25/2012 | CN102427829A Hiv-1的脂肽抑制剂 Hiv-1 lipopeptide inhibitor |
| 04/25/2012 | CN102427828A 含具有信号肽的细菌毒素作为载体的半抗原-载体缀合物和它们在免疫原性组合物中的用途 As a carrier-hapten having a signal peptide-containing bacterial toxin - the carrier conjugates and their use in the immunogenic compositions |
| 04/25/2012 | CN102427821A Compositions and methods for treatment of hemorrhage |
| 04/25/2012 | CN102427804A 降低胆固醇水平的脂质体 Lower cholesterol levels in liposomes |
| 04/25/2012 | CN102427802A 使用磺胺嘧啶银和壳聚糖制备的药用乳膏以及其制备方法 The use of silver sulfadiazine and chitosan medicinal creams and methods for their preparation |
| 04/25/2012 | CN102427801A 使用硫酸新霉素b乳膏和壳聚糖制备的药用乳膏以及其制备方法 Use of neomycin sulfate and chitosan prepared b cream pharmaceutical creams and their preparation |
| 04/25/2012 | CN102427800A 将活性剂优先分配到损伤部位的组合物和方法 The active agent is preferentially allocated to the damaged site of the compositions and methods |
| 04/25/2012 | CN102427797A Apigenin-containing composition |
| 04/25/2012 | CN102423494A CdTe/ZnS/聚醚/叶酸核壳型纳米颗粒的制法 CdTe / ZnS / polyether / folic acid core-shell nanoparticles prepared by |
| 04/25/2012 | CN102423492A 一种莱菔硫烷的包合物及其制备方法 One kind of inclusion compound sulforaphane and its preparation method |
| 04/25/2012 | CN102423491A 一种聚胺型两亲嵌段聚电解质在制备药物载体中的应用 An amphiphilic block polyamine type polyelectrolyte used in the preparation of the drug carrier |
| 04/25/2012 | CN102423490A Nano-hybrid of brufen and hydrotalcite-like and preparation method thereof |
| 04/25/2012 | CN102423482A 复方氨氯地平赖诺普利片的制备方法 Preparation of compound amlodipine lisinopril tablets |
| 04/25/2012 | CN102423352A Chinese medicinal granules for treating cardio-cerebrovascular diseases |
| 04/25/2012 | CN102423340A 姜厚朴配方颗粒及其制备方法 Ginger Magnolia officinalis formula particles and preparation method |
| 04/25/2012 | CN102423336A 一种治疗奶牛子宫炎的药物配方 A method of treating cows metritis pharmaceutical formulations |
| 04/25/2012 | CN102423332A 用于治疗青光眼的药物及其制备方法 Glaucoma medications and preparation methods for |
| 04/25/2012 | CN102423330A 一种滇桂艾纳香片及其制备工艺 One kind of Yunnan and Guangxi Ena Jasmine and preparation process |
| 04/25/2012 | CN102423315A 一种复方莫西沙星纳米乳及其制备方法 A nanoemulsion moxifloxacin compound and its preparation method |
| 04/25/2012 | CN102423311A 一种奥扎格雷钠注射液及其制备方法 One of sodium injection and preparation method Ozagrel |
| 04/25/2012 | CN102423306A 一种阿奇霉素肠溶胶囊 One kind of Azithromycin enteric-coated capsules |
| 04/25/2012 | CN102423303A Tirofiban hydrochloride lyophilization powder injection |
| 04/25/2012 | CN102423302A 载鬼臼苦素纳米胶束制剂和冻干制剂及其制备方法 Upload picropodophyllin micelle formulations and lyophilized formulation and preparation method |
| 04/25/2012 | CN102423301A 紫杉醇纳米胶束的制备方法 Preparation of paclitaxel micelles |
| 04/25/2012 | CN102423300A 乙酰氨基阿维菌素缓释微球及制备方法和缓释微球注射液 Eprinomectin release microsphere preparation method and sustained release microsphere injection |
| 04/25/2012 | CN102423299A Preparation method for novel drug-loaded chitosan nano-microspheres |
| 04/25/2012 | CN102423298A Preparation method of core-shell structure collagen polypeptide chelated calcium nanoparticle |